Using stem cells to treat type I diabetes is showing promise, says this news report. In this week’s issue of JAMA, scientists report preliminary results that giving diabetes patients their own nonmyeloablative hematopoietic stem cells after a course of immunosuppression could help treat newly diagnosed patients.
No word on how many patients this will help if they're required to correctly pronounce the name of the stem cells they need.